JP Morgan analyst David Low upgrades ResMed (NYSE:RMD) from Neutral to Overweight and raises the price target from $260 to $270.
Rent-A-Center Q2 Adj. EPS $1.63 Beats $1.35 Estimate, Sales $1.16B Beat $1.14B Estimate
Rent-A-Center (NASDAQ:RCII) reported quarterly earnings of $1.63 per share which beat the analyst consensus estimate of $1.35 by 20.74 percent. This is a 103.75 percent increase over earnings of $0.80 per share from the
